Evaluation of clinical significance of kallistatin and macrophage inflammatory protein-1b for the diagnosis of liver cirrhosis and hepatocellular carcinoma in Egyptian patients
[...]the early diagnosis of liver diseaseas is the only solution for this great problem [3]. [...]The final diagnosis of cirrhosis depends on the histological examination of liver tissue. [5] Series of new reliable biomarkers for early stages of liver cirrhosis and HCC is needed to improve clinical...
Gespeichert in:
Veröffentlicht in: | Research journal of pharmacy and technology 2019, Vol.12 (1), p.43-49 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 49 |
---|---|
container_issue | 1 |
container_start_page | 43 |
container_title | Research journal of pharmacy and technology |
container_volume | 12 |
creator | Abas, Al-Shimaa M. Abdelhamid, Moustafa Salaheldein Said, Noha Mohamed Sabea, Marwa Sayed |
description | [...]the early diagnosis of liver diseaseas is the only solution for this great problem [3]. [...]The final diagnosis of cirrhosis depends on the histological examination of liver tissue. [5] Series of new reliable biomarkers for early stages of liver cirrhosis and HCC is needed to improve clinical diagnosis and results. [...]the marker should be sensitive, easily measurable and minimally invasive. DISCUSSION Liver cirrhosis and hepatocellular carcinoma represent a worldwide global challenge. [...]liver transplantation is the most effective treatment for chronic liver diseases. According to this strategy, we assumed Kallistatin and chemokine CCl4 for evaluation as a prognostic markers for LC and HCC patients. |
doi_str_mv | 10.5958/0974-360X.2019.00009.X |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2269873588</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2269873588</sourcerecordid><originalsourceid>FETCH-LOGICAL-c198t-71a8a5393af8844d9ed7af7572b9e6e51f903d9289222e46f80315c197a3e84f3</originalsourceid><addsrcrecordid>eNo9kd1qAyEQhZfSQkOaVyhCrzdddX_0soT0BwK9aSF3MtnVxNTVrZpA3qqPWDcp9cbB880ZnJNl97iYV7xijwVvypzWxXpOCsznRTp8vr7KJv_C9X-N2W02C2E_QjWrSMkm2c_yCOYAUTuLnEKt0Va3YFDQW6tVKm0rR-ELjNEhJtAisB3qofVu2MFWIm2Vgb6H6PwJDd5FqW2ON0g5j-JOok7D1rqgw-hj9FF61Grvd-en0Wsnh9TcSmMOBpIIvtXW9ZCc0XJ7GqIGixKipY3hLrtRYIKc_d3T7PN5-bF4zVfvL2-Lp1XeYs5i3mBgUFFOQTFWlh2XXQOqqRqy4bKWFVa8oB0njBNCZFkrVlBcpd4GqGSlotPs4eKbfvR9kCGKvTt4m0YKQmrOGloxlqj6QqVthOClEoPXPfiTwIUYAxLj7sWYgxgDEueAxJr-Asd4iEQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2269873588</pqid></control><display><type>article</type><title>Evaluation of clinical significance of kallistatin and macrophage inflammatory protein-1b for the diagnosis of liver cirrhosis and hepatocellular carcinoma in Egyptian patients</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Abas, Al-Shimaa M. ; Abdelhamid, Moustafa Salaheldein ; Said, Noha Mohamed ; Sabea, Marwa Sayed</creator><creatorcontrib>Abas, Al-Shimaa M. ; Abdelhamid, Moustafa Salaheldein ; Said, Noha Mohamed ; Sabea, Marwa Sayed</creatorcontrib><description>[...]the early diagnosis of liver diseaseas is the only solution for this great problem [3]. [...]The final diagnosis of cirrhosis depends on the histological examination of liver tissue. [5] Series of new reliable biomarkers for early stages of liver cirrhosis and HCC is needed to improve clinical diagnosis and results. [...]the marker should be sensitive, easily measurable and minimally invasive. DISCUSSION Liver cirrhosis and hepatocellular carcinoma represent a worldwide global challenge. [...]liver transplantation is the most effective treatment for chronic liver diseases. According to this strategy, we assumed Kallistatin and chemokine CCl4 for evaluation as a prognostic markers for LC and HCC patients.</description><identifier>ISSN: 0974-3618</identifier><identifier>EISSN: 0974-360X</identifier><identifier>EISSN: 0974-306X</identifier><identifier>DOI: 10.5958/0974-360X.2019.00009.X</identifier><language>eng</language><publisher>Raipur: A&V Publications</publisher><subject>Alcohol ; Biomarkers ; Biopsy ; Chemokines ; Clinical medicine ; Clinical significance ; Hepatitis ; Hypertension ; Infections ; Inflammation ; Liver cancer ; Liver cirrhosis ; Liver diseases ; Physiology ; Proteins ; Variance analysis ; Viral infections</subject><ispartof>Research journal of pharmacy and technology, 2019, Vol.12 (1), p.43-49</ispartof><rights>Copyright A&V Publications Jan 2019</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c198t-71a8a5393af8844d9ed7af7572b9e6e51f903d9289222e46f80315c197a3e84f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids></links><search><creatorcontrib>Abas, Al-Shimaa M.</creatorcontrib><creatorcontrib>Abdelhamid, Moustafa Salaheldein</creatorcontrib><creatorcontrib>Said, Noha Mohamed</creatorcontrib><creatorcontrib>Sabea, Marwa Sayed</creatorcontrib><title>Evaluation of clinical significance of kallistatin and macrophage inflammatory protein-1b for the diagnosis of liver cirrhosis and hepatocellular carcinoma in Egyptian patients</title><title>Research journal of pharmacy and technology</title><description>[...]the early diagnosis of liver diseaseas is the only solution for this great problem [3]. [...]The final diagnosis of cirrhosis depends on the histological examination of liver tissue. [5] Series of new reliable biomarkers for early stages of liver cirrhosis and HCC is needed to improve clinical diagnosis and results. [...]the marker should be sensitive, easily measurable and minimally invasive. DISCUSSION Liver cirrhosis and hepatocellular carcinoma represent a worldwide global challenge. [...]liver transplantation is the most effective treatment for chronic liver diseases. According to this strategy, we assumed Kallistatin and chemokine CCl4 for evaluation as a prognostic markers for LC and HCC patients.</description><subject>Alcohol</subject><subject>Biomarkers</subject><subject>Biopsy</subject><subject>Chemokines</subject><subject>Clinical medicine</subject><subject>Clinical significance</subject><subject>Hepatitis</subject><subject>Hypertension</subject><subject>Infections</subject><subject>Inflammation</subject><subject>Liver cancer</subject><subject>Liver cirrhosis</subject><subject>Liver diseases</subject><subject>Physiology</subject><subject>Proteins</subject><subject>Variance analysis</subject><subject>Viral infections</subject><issn>0974-3618</issn><issn>0974-360X</issn><issn>0974-306X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNo9kd1qAyEQhZfSQkOaVyhCrzdddX_0soT0BwK9aSF3MtnVxNTVrZpA3qqPWDcp9cbB880ZnJNl97iYV7xijwVvypzWxXpOCsznRTp8vr7KJv_C9X-N2W02C2E_QjWrSMkm2c_yCOYAUTuLnEKt0Va3YFDQW6tVKm0rR-ELjNEhJtAisB3qofVu2MFWIm2Vgb6H6PwJDd5FqW2ON0g5j-JOok7D1rqgw-hj9FF61Grvd-en0Wsnh9TcSmMOBpIIvtXW9ZCc0XJ7GqIGixKipY3hLrtRYIKc_d3T7PN5-bF4zVfvL2-Lp1XeYs5i3mBgUFFOQTFWlh2XXQOqqRqy4bKWFVa8oB0njBNCZFkrVlBcpd4GqGSlotPs4eKbfvR9kCGKvTt4m0YKQmrOGloxlqj6QqVthOClEoPXPfiTwIUYAxLj7sWYgxgDEueAxJr-Asd4iEQ</recordid><startdate>2019</startdate><enddate>2019</enddate><creator>Abas, Al-Shimaa M.</creator><creator>Abdelhamid, Moustafa Salaheldein</creator><creator>Said, Noha Mohamed</creator><creator>Sabea, Marwa Sayed</creator><general>A&V Publications</general><scope>AAYXX</scope><scope>CITATION</scope><scope>04Q</scope><scope>04S</scope><scope>04W</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>2019</creationdate><title>Evaluation of clinical significance of kallistatin and macrophage inflammatory protein-1b for the diagnosis of liver cirrhosis and hepatocellular carcinoma in Egyptian patients</title><author>Abas, Al-Shimaa M. ; Abdelhamid, Moustafa Salaheldein ; Said, Noha Mohamed ; Sabea, Marwa Sayed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c198t-71a8a5393af8844d9ed7af7572b9e6e51f903d9289222e46f80315c197a3e84f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Alcohol</topic><topic>Biomarkers</topic><topic>Biopsy</topic><topic>Chemokines</topic><topic>Clinical medicine</topic><topic>Clinical significance</topic><topic>Hepatitis</topic><topic>Hypertension</topic><topic>Infections</topic><topic>Inflammation</topic><topic>Liver cancer</topic><topic>Liver cirrhosis</topic><topic>Liver diseases</topic><topic>Physiology</topic><topic>Proteins</topic><topic>Variance analysis</topic><topic>Viral infections</topic><toplevel>online_resources</toplevel><creatorcontrib>Abas, Al-Shimaa M.</creatorcontrib><creatorcontrib>Abdelhamid, Moustafa Salaheldein</creatorcontrib><creatorcontrib>Said, Noha Mohamed</creatorcontrib><creatorcontrib>Sabea, Marwa Sayed</creatorcontrib><collection>CrossRef</collection><collection>India Database</collection><collection>India Database: Business</collection><collection>India Database: Science & Technology</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Research journal of pharmacy and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abas, Al-Shimaa M.</au><au>Abdelhamid, Moustafa Salaheldein</au><au>Said, Noha Mohamed</au><au>Sabea, Marwa Sayed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of clinical significance of kallistatin and macrophage inflammatory protein-1b for the diagnosis of liver cirrhosis and hepatocellular carcinoma in Egyptian patients</atitle><jtitle>Research journal of pharmacy and technology</jtitle><date>2019</date><risdate>2019</risdate><volume>12</volume><issue>1</issue><spage>43</spage><epage>49</epage><pages>43-49</pages><issn>0974-3618</issn><eissn>0974-360X</eissn><eissn>0974-306X</eissn><abstract>[...]the early diagnosis of liver diseaseas is the only solution for this great problem [3]. [...]The final diagnosis of cirrhosis depends on the histological examination of liver tissue. [5] Series of new reliable biomarkers for early stages of liver cirrhosis and HCC is needed to improve clinical diagnosis and results. [...]the marker should be sensitive, easily measurable and minimally invasive. DISCUSSION Liver cirrhosis and hepatocellular carcinoma represent a worldwide global challenge. [...]liver transplantation is the most effective treatment for chronic liver diseases. According to this strategy, we assumed Kallistatin and chemokine CCl4 for evaluation as a prognostic markers for LC and HCC patients.</abstract><cop>Raipur</cop><pub>A&V Publications</pub><doi>10.5958/0974-360X.2019.00009.X</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0974-3618 |
ispartof | Research journal of pharmacy and technology, 2019, Vol.12 (1), p.43-49 |
issn | 0974-3618 0974-360X 0974-306X |
language | eng |
recordid | cdi_proquest_journals_2269873588 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Alcohol Biomarkers Biopsy Chemokines Clinical medicine Clinical significance Hepatitis Hypertension Infections Inflammation Liver cancer Liver cirrhosis Liver diseases Physiology Proteins Variance analysis Viral infections |
title | Evaluation of clinical significance of kallistatin and macrophage inflammatory protein-1b for the diagnosis of liver cirrhosis and hepatocellular carcinoma in Egyptian patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T21%3A16%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20clinical%20significance%20of%20kallistatin%20and%20macrophage%20inflammatory%20protein-1b%20for%20the%20diagnosis%20of%20liver%20cirrhosis%20and%20hepatocellular%20carcinoma%20in%20Egyptian%20patients&rft.jtitle=Research%20journal%20of%20pharmacy%20and%20technology&rft.au=Abas,%20Al-Shimaa%20M.&rft.date=2019&rft.volume=12&rft.issue=1&rft.spage=43&rft.epage=49&rft.pages=43-49&rft.issn=0974-3618&rft.eissn=0974-360X&rft_id=info:doi/10.5958/0974-360X.2019.00009.X&rft_dat=%3Cproquest_cross%3E2269873588%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2269873588&rft_id=info:pmid/&rfr_iscdi=true |